PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 132 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,455,697 | -34.3% | 87,272 | +8.8% | 0.00% | 0.0% |
| Q2 2023 | $2,215,124 | +77.7% | 80,200 | +48.0% | 0.00% | 0.0% |
| Q1 2023 | $1,246,600 | +110.8% | 54,200 | 0.0% | 0.00% | – |
| Q4 2022 | $591,322 | +75.5% | 54,200 | +35.5% | 0.00% | – |
| Q3 2022 | $337,000 | -7.4% | 40,000 | -13.0% | 0.00% | – |
| Q2 2022 | $364,000 | -87.8% | 46,000 | -63.6% | 0.00% | -100.0% |
| Q1 2022 | $2,995,000 | +90.8% | 126,463 | +175.5% | 0.00% | 0.0% |
| Q4 2021 | $1,570,000 | +93.1% | 45,900 | 0.0% | 0.00% | – |
| Q3 2021 | $813,000 | -60.5% | 45,900 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $2,060,000 | +159.8% | 45,900 | +50.0% | 0.00% | – |
| Q1 2021 | $793,000 | +40.6% | 30,600 | +9.3% | 0.00% | – |
| Q4 2020 | $564,000 | +3.1% | 28,000 | 0.0% | 0.00% | – |
| Q3 2020 | $547,000 | +10.7% | 28,000 | 0.0% | 0.00% | – |
| Q2 2020 | $494,000 | +333.3% | 28,000 | +73.9% | 0.00% | – |
| Q1 2020 | $114,000 | +28.1% | 16,100 | +27.8% | 0.00% | – |
| Q4 2019 | $89,000 | -41.1% | 12,600 | 0.0% | 0.00% | – |
| Q3 2019 | $151,000 | – | 12,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $67,646,434 | 21.00% |
| COWEN AND COMPANY, LLC | 1,657,551 | $45,781,558 | 3.80% |
| Kynam Capital Management, LP | 975,298 | $26,937,731 | 3.70% |
| BVF INC/IL | 3,775,900 | $104,290,358 | 2.91% |
| RTW INVESTMENTS, LP | 5,415,514 | $149,576,497 | 2.85% |
| Cormorant Asset Management, LP | 1,500,000 | $41,430,000 | 2.32% |
| Ghost Tree Capital, LLC | 225,000 | $6,214,500 | 2.05% |
| 683 Capital Management, LLC | 814,000 | $22,482,680 | 1.62% |
| Perceptive Advisors | 1,469,761 | $40,594,799 | 1.18% |
| Artia Global Partners LP | 112,340 | $3,102,831 | 1.07% |